Current active clinical trials:

1. REPRIEVE: Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults, https://clinicaltrials.gov/ct2/show/NCT02344290?term=A5332&rank=1

2. IRC 003: Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications, https://clinicaltrials.gov/ct2/show/NCT01227967?term=IRC003&rank=1

3. Gilead GS-US-366-1160: Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults, https://clinicaltrials.gov/ct2/show/NCT02345226?term=GS-US-366-1160&rank=1

4. Gilead GS-US-366-1216: Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF), https://clinicaltrials.gov/ct2/show/NCT02345252?term=GS-US-366-1216&rank=1

5. BMS AI438-47: Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients, https://clinicaltrials.gov/ct2/show/NCT02362503?term=AI438-047&rank=1